Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Jupiter Life Line Hospitals Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹735
Per ShareLot Size
20 Shares
Minimum Investment
₹14,700
Issue Size
₹869.08 Cr
Face Value
₹10
Per ShareIPO Type
Book Building
Retail Quota
35%
QIB Quota
50%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
40.69%
Issue Type
Book Building
ISIN
INE682M01020
Jupiter Life Line Hospitals Limited is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area and western region of India with a total bed capacity of 1,194 hospital beds across three hospitals as of March 31, 2023. The Hospital has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates its hospitals located in Thane, Pune and Indore under the "Jupiter" brand. The Hospital is also currently in the process of developing a multispecialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds.
The healthcare market for west India is expected to grow at a CAGR of 14%-16% from Rs. 1.05-Rs. 1.15 trillion in Fiscal 2022 to Rs.2.15-Rs.2.25 trillion in Fiscal 2027. Lower penetration of chained hospitals, high population density of the region, increasing average revenue per occupied bed figures of private players in the region and increasing penetration of health insurance in the region are expected to drive the growth of the healthcare delivery market in the western region of India. The western region being better served by health insurance will also support the growth of healthcare delivery market.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of 11,824,163** equity shares of face value of Rs. 10 each of the company ("Equity Shares") for cash at a price of Rs. 735 per equity share (including a share premium of Rs. 725 per equity share) ("Offer Price") aggregating to Rs. 869.08 crores (the "Offer") comprising of a fresh issue of 7,374,163** equity shares aggregating to Rs. 542.00 crores ("Fresh Issue") and an offer for sale of 4,450,000** equity shares ("Offered Shares") aggregating to Rs. 327.08 crores comprising 1,250,000** equity shares by Devang Vasantlal Gandhi (huf) aggregating to Rs. 91.88 crores, 900,000** equity shares by Devang Gandhi jointly with Neeta Gandhi aggregating to Rs. 66.15 crores, 1,000,000** equity shares by Nitin Thakker jointly with Asha Thakker aggregating to Rs. 73.50 crores, 400,000** equity shares by Anuradha Ramesh Modi with Megha Ramesh Modi (as trustees for the benefit of modi family private trust) aggregating to Rs. 29.40 crores, 400,000** equity shares by Bhaskar P Shah (huf) aggregating to Rs. 29.40 crores, 200,000** equity shares by Rajeshwari Capital Market Limited aggregating to Rs. 14.70 crores, 200,000** equity shares by Vadapatra Sayee Raghavan (huf) aggregating to Rs. 14.70 crores, 40,000 equity shares by Sangeeta Ravat jointly with Hasmukh Ravat aggregating to Rs. 2.94 crores, 40,000** equity shares by Hasmukh Ravat jointly with Sangeeta Ravat aggregating to Rs. 2.94 crores and 20,000** equity shares by Shreyas Ravat jointly with Sangeeta Ravat aggregating to Rs. 1.47 crores (together, the "Selling Shareholders", and such offer for sale of equity shares by the selling shareholders, the "Offer for Sale"). The offer shall constitute 18.03% of the post-offer paid up equity share capital of the company. **Subject to finalization of the basis of allotment. The company, in consultation with the book running lead managers, has undertaken a pre-ipo placement of 1,673,469 equity shares aggregating to Rs. 123.00 crores. consequently, the size of the fresh issue has been reduced by Rs. 123.00 crores pursuant to the pre-ipo placement and accordingly, the fresh issue now comprises of 7,374,163** equity shares aggregating to Rs. 542.00 crores. The face value of the equity share is Rs. 10 each. The offer price is 735 and is 73.5 times the face value of the equity shares.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
The Company was incorporated as `Jupiter Life Line Hospitals Limited' at Mumbai, Maharashtra as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. the Company commenced its business on December 24, 2002.
Densely populated micro markets in the western regions of India.
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.